Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Shares Outstanding (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Shares Outstanding for 3 consecutive years, with $44.5 million as the latest value for Q2 2022.

  • On a quarterly basis, Shares Outstanding rose 668.96% to $44.5 million in Q2 2022 year-over-year; TTM through Jun 2022 was $44.5 million, a 668.96% increase, with the full-year FY2021 number at $43.7 million, up 826.71% from a year prior.
  • Shares Outstanding was $44.5 million for Q2 2022 at PROCEPT BioRobotics, up from $44.1 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $44.5 million in Q2 2022 to a low of $4.6 million in Q3 2020.
  • A 3-year average of $24.5 million and a median of $24.6 million in 2021 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: skyrocketed 840.95% in 2021, then soared 668.96% in 2022.
  • PROCEPT BioRobotics' Shares Outstanding stood at $4.7 million in 2020, then surged by 826.71% to $43.7 million in 2021, then rose by 1.97% to $44.5 million in 2022.
  • Per Business Quant, the three most recent readings for PRCT's Shares Outstanding are $44.5 million (Q2 2022), $44.1 million (Q1 2022), and $43.7 million (Q4 2021).